Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 21, Issue 4, 2009, Pages 448-455

  Royal, Scott W ^a   Kidder, Daniel P ^b   Patrabansh, Satyendra ^a   Wolitski, Richard J ^b   Holtgrave, David R ^c   Aidala, Angela ^d   Pals, Sherri ^b   Stall, Ron ^e  

^a ABT ASSOCIATES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Columbia University ^*  (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adherence; HAART; HIV; Homeless; Mental health; Substance use

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; ATTITUDE TO HEALTH; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; EDUCATION; FEMALE; GENDER; HEALTH CARE ACCESS; HEALTH INSURANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMELESSNESS; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; MENTAL HEALTH; MENTAL HEALTH CARE; MENTAL STRESS; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PERCEIVED STRESS SCALE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK FACTOR; SCORING SYSTEM; SELF CONCEPT; SELF REPORT; SHORT FORM 36; SOCIAL WORK; SUBSTANCE ABUSE; UNITED STATES; ADOLESCENT; AGED; CROSS-SECTIONAL STUDY; HEALTH CARE DELIVERY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HOMELESS PERSONS; HOUSING; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; REGRESSION ANALYSIS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 67649403729     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120802270250     Document Type: Article

References (31)

1. Arnsten, J., Gourevitch, M., Handley, K., Knight, K., Knowlton, A., Metsch, L., et al. (2005). Factors associated with antiretroviral therapy adherence in injection drug users. Paper presented at the 12th conference on retroviruses and opportunistic infections, Boston, MA.
2. Bangsberg, D., Tulsky, J.P., Hecht, F.M., & Moss, A.R. (1997). Protease inhibitors in the homeless. Journal of the American Medical Association, 278, 63-65.
3. Bangsberg, D.R. (2006). Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases, 43, 939-941.
4. Bangsberg, D.R., Hecht, F.M., Charlebois, E.D., Zolopa, A.R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development ofdrug resistance in an indigent population. AIDS, 14(4), 357-366.
5. Boyer A., & Indyk, D. (2005). Shaping garments ofcare tools for maximizing adherence potential. Social Work Health Care, 42(3-4), 151-166.
6. Catz, S.L., Kelly, J.A., Bogart, L.M., Benotsch, E.G., & McAuliffe, T.L. (2000). Patterns, correlates and barriers to medication adherence among person prescribed new treatment for HIV disease. Health Psychology, 19, 124-133.
7. Celentano, D.D., Vlahov, D., Cohn, S., Shadle, V.M., Obasanjo, O., & Moore, R.D. (1998). Self-reported antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 544-546.
8. Chesney, M.A., Morin, M., & Sherr, L. (2000). Adherence to HIV combination therapy. Social Science Medicine, 50(11), 1599-1605.
9. Cohen, S., Kamark, T., & Mermelstein, R. (1983). A global measure ofperceived stress. Journal of Health and Social Behavior, 24, 385-396.
10. Department ofHealth and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. (2006). Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Retrieved June 18, 2007, fromhttp://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
11. DiMatteo, M.R., Lepper, H.S., & Croghan, T.W. (2000). Depression is a risk factor for noncompliance with medical treatment. Archives of Internal Medicine, 160, 2101-2107.
12. Gandek, B., & Ware, J.E. (1998). Methods for validating and norming translations ofhealth status questionnaires: The IQOLA Project approach. International Quality ofLif e Assessment. Journal of Clinical Epidemiology, 51, 953-959.
13. Gordillo, V., del Amo, J., Soriano, V., & Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
14. Johnson, M.O., Elliott, T.R., Neilands, T.B., Morin, S.F., & Chesney, M.A., et al. (2006). A social problemsolving model ofadherence to HIV medications. Health Psychology, 25(3), 355-363.
15. Kidder, D.P., Wolitski, R.J., Royal, S., Aidala, A., Courtenay-Quirck, C., & Holtgrave, D., et al. (2007). Access to housing as a structural intervention for homeless and unstably housed people living with HIV: Rationale, methods, and implementation ofthe Housing and Health Study. AIDS & Behavior, 11(Suppl. 6), S149-S161.
16. Knowlton, A., Arnsten, J., Eldred, L., Wilkinson, J., Gourevitch, M., Shade, S., et al. (2006). Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. Journal of Acquired Immune Deficiency Syndromes, 41(4), 486-492.
17. Moss, A.R., Hahn, J.A., Perry, S., Charlebois, E.D., Guzman, D., & Clark, R.A., et al. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases, 39, 1190-1198.
18. Nilsson, S.L., Diamond, P.M., Ross, M.W., Williams, M., & Bratt, G. (2006). Baseline predictors for three types ofantiretroviral therapy (ART) adherence: A 2-year follow-up. AIDS Care, 18(4), 407-414.
19. Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., & Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
20. Perno, C.F., Ceccherini-Silberstein, F., DeLuca, A., Cozzi- Lepri, A., Gori, C., & Cingolani, A., et al. (2002). Virologic correlates ofadherence to antiretroviral medications and therapeutic failure. Journal of Acquired Immune Deficiency Syndromes, 31(Suppl. 3), S118-S122.
21. Radloff, L.S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
22. Riley, E.D., Wu, A.W., Perry, S, Clark, R.A., Moss, A.R., & Crane, J., et al. (2003). Depression and drug use impact health status among marginally housed HIVinfected individuals. AIDS Patient Care and STDs, 17, 401-406.
23. Roberts, K.J., & Volberding, P. (1999). Adherence communication: A qualitative analysis ofphysician patient dialogue. AIDS, 13, 1771-1778.
24. Shapiro, M.F., Morton, S.C., McCaffrey, D.F., Senterfitt, J.W., Fleishman, J.A., & Perlman, J.F., et al. (1999). Variations in the care ofHIV-inf ected adults in the United States: Results from the HIV cost and services utilization study. Journal of the American Medical Association, 281, 2305-2315.
25. Starace, F., Ammassari, A., Trotta, M.P., Murri, R., De Longis, P., & Izzo, C. (2002). Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. Journal of the Acquired Immune Deficiency Syndromes, 31(Suppl. 3), S136-S139. (Pubitemid 35453574)
26. Tesorio, J., French, T., Weiss, L., Waters, M., Finkelstein, R., & Agins, B. (2003). Stability ofadherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstrationproject. Journal of the Acquired Immune Deficiency Syndromes, 33, 484-493.
27. Van Vaerenbergh, K., De Geest, S., Derdelinckx, I., Bobbaers, H., Carbonez, A., & Deschamps A., et al. (2002). A combination ofpoor adherence and a low baseline susceptibility score is highly predictive for HAART failure. Antiviral Chemistry and Chemotherapy, 13, 231-240.
28. Waldrop-Valverde, D., & Valverde, E. (2005). Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive drug users. AIDS Patient Care and STDs, 19(5), 326-334.
29. Ware, J.E., & Gandek, B. (1998). Overview ofthe SF-36 health survey and the International Quality ofLif e (IQOL) Project. Journal Clinical Epidemiology, 51, 903-912.
30. Wong, M.D., Cunningham, W.E., Shapiro, M.F., Andersen, R.M., Cleary, P.D., & Duan, N., et al. (2004). Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients. Journal of General Internal Medicine, 19, 366- 374.
31. Wood, E., Montaner, J.S., Yip, B., Tyndall, M.W., Schechter, M.T., O'Shaughnessy, M.V., et al. (2003). Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. Canadian Medical Association Journal, 169(7), 656-661.